1. Home
  2. OLMA vs EOI Comparison

OLMA vs EOI Comparison

Compare OLMA & EOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olema Pharmaceuticals Inc.

OLMA

Olema Pharmaceuticals Inc.

HOLD

Current Price

$10.27

Market Cap

949.3M

Sector

Health Care

ML Signal

HOLD

Logo Eaton Vance Enhance Equity Income Fund Eaton Vance Enhanced Equity Income Fund Shares of Beneficial Interest

EOI

Eaton Vance Enhance Equity Income Fund Eaton Vance Enhanced Equity Income Fund Shares of Beneficial Interest

HOLD

Current Price

$20.12

Market Cap

817.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLMA
EOI
Founded
2006
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
949.3M
817.2M
IPO Year
2020
2004

Fundamental Metrics

Financial Performance
Metric
OLMA
EOI
Price
$10.27
$20.12
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
$44.89
N/A
AVG Volume (30 Days)
939.2K
72.1K
Earning Date
05-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
15.00
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.36
$18.04
52 Week High
$36.26
$21.58

Technical Indicators

Market Signals
Indicator
OLMA
EOI
Relative Strength Index (RSI) 42.12 56.79
Support Level $9.70 $20.12
Resistance Level $11.36 $20.16
Average True Range (ATR) 0.50 0.17
MACD -0.01 -0.01
Stochastic Oscillator 46.99 59.85

Price Performance

Historical Comparison
OLMA
EOI

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About EOI Eaton Vance Enhance Equity Income Fund Eaton Vance Enhanced Equity Income Fund Shares of Beneficial Interest

Eaton Vance Enhanced Equity Income Fund offers mutual funds that invest across a wide array of equity, income, and alternative strategies. The primary investment objective of the fund is to provide current income, with a secondary objective of capital appreciation. The company's sector allocation includes: Information Technology, Communication Services, Financials, Consumer Discretionary, Healthcare, Industries, Consumer Staples, Energy, Real Estate, and Materials.

Share on Social Networks: